Delivery Order SPE2DR25D2102-SPE2DR26FB2KL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a ceiling value of $1,385.52. This competitive award, utilizing firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order is...
- The Defense Logistics Agency awarded a $26,282.34 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of ORGOVYX 120 mg tablets (30-count units). This is a firm fixed-price contract with an ultimate completion date of January 2, 2026, and no set-aside designation was utilized in the award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is the prime contractor fulfilling this order under its broader...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This competitive, non-set-aside contract has a ceiling value of $1,460.13 and is scheduled for completion by January 2, 2026. The order is priced on a firm fixed-price basis and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,460.13 and an ultimate completion date of January 7, 2026. The contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $2,920.26 and an ultimate completion date of December 22, 2025. The contract is unclassified as a set-aside award and represents a competitive procurement for pharmaceutical products supporting federal medical supply needs. Performance will be executed from...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 11, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a contract ceiling value of $2,771.04. The award represents a firm fixed-price delivery order with an ultimate completion date of August 1, 2025. This contract was competitively awarded without set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of ORGOVYX 120 mg tablets (30-count units) valued at $4,156.56 with a firm fixed price arrangement. This is a non-set-aside competitive award with an ultimate completion date of May 15, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,313.12 on July 29, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 19, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,460.13 and an ultimate completion date of November 19, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a $8,313.12 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of ORGOVYX 120 mg tablets (30-count unit of use packaging). This firm fixed-price contract, with a completion date of September 25, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award was made through open competition...
- SPE2DR25D2102Indefinite Delivery Contract
- SPE2DR25D2102-SPE2DR26FB2KLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,460.13 and an ultimate completion date of January 13, 2026. The contract represents a non-competitive award executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026 that serves as the comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's performance location is identified as its corporate office in Conshohocken, PA. This delivery order exemplifies AmerisourceBergen's role in supplying specialized pharmaceutical products across multiple therapeutic domains to the Defense Health Agency and other government healthcare systems through the flexible IDC vehicle, with no set-aside designation applied to this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/18/25 |